Humacyte Inc. (NASDAQ: HUMA)
$8.09
-0.7000 ( -7.96% ) 2.4M
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.
Market Data
Open
$8.09
Previous close
$8.79
Volume
2.4M
Market cap
$961.61M
Day range
$8.04 - $8.86
52 week range
$1.96 - $9.97
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
def | Proxies and info statements | 6 | Apr 29, 2024 |
10-k | Annual reports | 129 | Mar 28, 2024 |
8-k | 8K-related | 16 | Mar 22, 2024 |
8-k | 8K-related | 22 | Mar 04, 2024 |
8-k | 8K-related | 57 | Feb 29, 2024 |
8-k | 8K-related | 17 | Feb 09, 2024 |
4 | Insider transactions | 1 | Dec 12, 2023 |
4 | Insider transactions | 1 | Dec 12, 2023 |
4 | Insider transactions | 1 | Dec 12, 2023 |
8-k | 8K-related | 15 | Dec 12, 2023 |